REDWOOD CITY, Calif.--(BUSINESS WIRE)--Suki, the leader in artificial intelligence (AI) technology for healthcare, today announced plans to partner with AI-first work platform and leading telehealth platform Zoom Video Communications, Inc. Zoom plans to use Suki’s AI engine, Suki Platform, to generate clinical notes and incorporate AI capabilities into its solution, enhancing user experience and ultimately improving patient care. Suki Platform enables large and small companies alike to build cutting-edge AI experiences with minimal development effort and already reaches nearly one million clinicians across the United States.
“With over almost 140,000 healthcare institutions globally using the Zoom platform, we feel a great responsibility to leverage the power of AI to drive employee productivity and enhance patient experiences,” said Smita Hashim, chief product officer at Zoom. “Working together with Suki to provide critical AI-generated clinical note functionality to Zoom Workplace for Clinicians will reduce documentation overhead for clinicians, allowing them to focus on patients.”
Suki plans to power ambient clinical documentation supporting Zoom telehealth visits and in-person visits. Studies have shown that AI-based clinical notes can help reduce physician note-taking by up to 70%, thereby increasing time spent with patients (Mayo Clinic).
“AI is changing the way we interact with the world,” said Suki founder and CEO, Punit Soni. “Everything from how we communicate to how we use technology to how care is delivered will evolve. Video will be a critical interface in the AI-driven world. We are thrilled to work with Zoom to develop new interaction models and AI that will advance our mission of making healthcare technology invisible and assistive so clinicians can focus on what’s most important: their patients.”
About Suki
Suki is a leading technology company that provides AI voice solutions for healthcare. Its mission is to reimagine the healthcare technology stack, making it invisible and assistive to lift the administrative burden from clinicians. Its flagship product is Suki Assistant, an AI assistant that uses generative AI to automatically create clinical documentation by ambiently listening to patient-clinician conversations. Suki helps clinicians complete notes 72% faster on average, assists with other tasks including coding and answering questions, and generates incremental revenue for organizations, delivering a 9X ROI in year 1. Suki also offers its proprietary AI and speech platform, Suki Platform, to partners who want to create best-in-class ambient and voice experiences for their solutions. Suki is backed by premier investors such as Venrock, First Round, Flare Capital Partners, March Capital, Hedosophia, and Breyer Capital. To learn more, visit suki.ai, or follow us on LinkedIn and Twitter.
